In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Cytos, Kuros merge to form leader in tissue repair and orthobiologics

Executive Summary

Public Swiss firm Cytos Biotechnology Ltd. and closely held Kuros Biosurgery AG are merging to create leading biosciences company in the tissue repair and regeneration space.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Acquisition of Private Biotech
    • Reverse Acquisition
    • Payment Includes Stock
    • Intra-Biotech Deal

Related Companies

Advertisement
UsernamePublicRestriction

Register